| 1 |
30836453 | Beta2 -adrenergic ligand racemic formoterol exhibits enantioselective disposition in blood and skeletal muscle of humans, and elicits myocellular PKA signaling at therapeutic inhaled doses. | 2019 Jul |
1 |
| 2 |
30865387 | Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control. | 2019 Jul |
1 |
| 3 |
31112386 | Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. | 2019 May 23 |
1 |
| 4 |
31468315 | Glycopyrronium/Formoterol: A Review in COPD. | 2019 Sep |
2 |
| 5 |
29332144 | Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed. | 2018 May |
1 |
| 6 |
30265259 | Advances in the treatment of mild asthma: recent evidence. | 2018 Sep 28 |
1 |
| 7 |
30368448 | Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. | 2018 Oct 27 |
1 |
| 8 |
27997807 | Roflumilast N-Oxide in Combination with Formoterol Enhances the Antiinflammatory Effect of Dexamethasone in Airway Smooth Muscle Cells. | 2017 Apr |
1 |
| 9 |
28453742 | Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae. | 2017 Jul 1 |
1 |
| 10 |
28757318 | New Treatment Option for Chronic Obstructive Pulmonary Disease: Two Long-Acting Bronchodilators in a Single Metered-Dose Inhaler. | 2017 Nov |
1 |
| 11 |
26098693 | Effect of Sphingosine 1-Phosphate on Cyclo-Oxygenase-2 Expression, Prostaglandin E2 Secretion, and β2-Adrenergic Receptor Desensitization. | 2016 Jan |
1 |
| 12 |
27147617 | Effect of formoterol, a long-acting β2-adrenergic agonist, on muscle strength and power output, metabolism, and fatigue during maximal sprinting in men. | 2016 Jun 1 |
2 |
| 13 |
27474345 | [Fixed-dose combination fluticasone propionate/formoterol for the treatment of asthma: a review of its pharmacology, efficacy and tolerability]. | 2016 Feb |
1 |
| 14 |
27552524 | Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease. | 2016 Oct |
1 |
| 15 |
27552906 | Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort(®) Turbuhaler(®) dry powder fixed combination aerosol drug. | 2016 Oct 10 |
1 |
| 16 |
25166221 | A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β₂-Agonists. | 2015 Jun |
1 |
| 17 |
25324048 | Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domains. | 2015 Jan |
1 |
| 18 |
25650070 | Formoterol, a highly β2-selective agonist, induces gender-dimorphic whole body leucine metabolism in humans. | 2015 Apr |
1 |
| 19 |
26082638 | Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma. | 2015 |
1 |
| 20 |
26233481 | Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). | 2015 Aug 2 |
1 |
| 21 |
26487878 | Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis. | 2015 May |
1 |
| 22 |
24341818 | Dry-powder inhalers in acute asthma. | 2014 Jan |
2 |
| 23 |
24669382 | Glycopyrronium for inhalation. COPD: another antimuscarinic with cardiac adverse effects that require monitoring. | 2014 Feb |
1 |
| 24 |
25051902 | Fluticasone propionate/formoterol: a fixed-combination therapy with flexible dosage. | 2014 Oct |
2 |
| 25 |
25060541 | A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD. | 2014 Sep |
2 |
| 26 |
25451347 | One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. | 2014 Dec |
1 |
| 27 |
27905766 | | 2014 Feb 12 |
1 |
| 28 |
22641064 | Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men. | 2013 Apr |
3 |
| 29 |
23348973 | β2-agonist therapy in lung disease. | 2013 Apr 1 |
1 |
| 30 |
23363416 | A review of mometasone furoate / formoterol in the treatment of asthma. | 2013 Feb |
1 |
| 31 |
23533638 | Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells. | 2013 |
1 |
| 32 |
23971870 | Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile. | 2013 Sep |
1 |
| 33 |
21778259 | Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis. | 2012 Feb |
1 |
| 34 |
22035853 | Real-life prospective study on asthma control in Italy: cross-sectional phase results. | 2012 Feb |
2 |
| 35 |
22251095 | Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition. | 2012 Oct |
1 |
| 36 |
22372570 | Corticosteroids and β₂-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms. | 2012 Aug |
1 |
| 37 |
22401993 | Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation. | 2012 Jun |
2 |
| 38 |
22447497 | Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis. | 2012 Jun |
2 |
| 39 |
23081745 | Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study. | 2012 Nov |
3 |
| 40 |
23088211 | Pharmacological modulation of the bradykinin-induced differentiation of human lung fibroblasts: effects of budesonide and formoterol. | 2012 Dec |
1 |
| 41 |
23102189 | Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety. | 2012 Dec |
3 |
| 42 |
27933599 | Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma : A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. | 2012 Jan |
1 |
| 43 |
21531015 | Therapeutic strategies to reduce asthma exacerbations. | 2011 Aug |
1 |
| 44 |
21603974 | The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts. | 2011 Aug |
3 |
| 45 |
21814459 | Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol. | 2011 |
1 |
| 46 |
21845007 | A comparative study of efficacy and safety of arformoterol and salbutamol nebulization as rescue therapy in acute non-severe asthma. | 2011 Jul |
1 |
| 47 |
22082160 | Mometasone furoate/formoterol in the treatment of persistent asthma. | 2011 Dec |
1 |
| 48 |
22085439 | Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results. | 2011 Nov 15 |
1 |
| 49 |
20406080 | Arformoterol tartrate in the treatment of COPD. | 2010 Apr |
1 |
| 50 |
21034447 | Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. | 2010 Oct 29 |
1 |